D
Amedisys, Inc. AMED
$91.79 $0.630.69%
Recommendation
Sell
Prev Close
$90.40
Volume
144,548
Avg Vol (90D)
304,693
Market Cap
$2.95B
Dividend & Yield
--
52-Week Range
$73.10 - $96.44
P/E (TTM)
--
EPS (TTM)
-$0.32
My Lists My Alerts
Report
Rating
Reward
C
Fair
Risk
D-
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Good
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
AMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q1 2024
4/25/2024 - InvestorPlace
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics
4/25/2024 - Zacks Investment Research
Amedisys (AMED) Q1 Earnings and Revenues Surpass Estimates
4/24/2024 - Zacks Investment Research
Amedisys reports Q1 EPS $1.03, consensus $1.02
4/24/2024 - The Fly
Amedisys Reports First Quarter 2024 Financial Results
4/24/2024 - Globe Newswire
Premium Growth Propels Humana (HUM) to Easy Q1 Earnings Beat
4/24/2024 - Zacks Investment Research
Amedisys (AMED) Earnings Expected to Grow: What to Know Ahead of Q1 Release
4/24/2024 - Zacks Investment Research
Here's Why Amedisys (AMED) is a Strong Value Stock
4/23/2024 - Zacks Investment Research
Should You Buy HCA Healthcare (HCA) Ahead of Q1 Earnings?
4/23/2024 - Zacks Investment Research
Quest Diagnostics (DGX) Beats Q1 Earnings and Revenue Estimates
4/23/2024 - Zacks Investment Research
UnitedHealth deal for Amedisys likely to close despite report of DOJ scrutiny - analyst
3/25/2024 - Seeking Alpha - Healthcare
UnitedHealth deal for Amedisys likely to close despite report of DOJ scrutiny - analyst
3/25/2024 - SeekingAlpha.com: All News
Why Amedisys (AMED) is a Top Value Stock for the Long-Term
3/25/2024 - Zacks Investment Research
Amedisys price target raised by $3 at RBC Capital, here's why
3/25/2024 - The Fly
Analysts Have Conflicting Sentiments on These Healthcare Companies: Amedisys (AMED) and Masimo (MASI)
3/25/2024 - TipRanks Financial Blog
Why Is Amedisys (AMED) Down 2.5% Since Last Earnings Report?
3/22/2024 - Zacks Investment Research
Amedisys dips amid report DOJ considering lawsuit to block UnitedHealth deal
3/20/2024 - Seeking Alpha - Healthcare
How Amedisys (AMED) Stock Stands Out in a Strong Industry
3/20/2024 - Zacks Investment Research
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
3/14/2024 - Zacks Investment Research
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
3/7/2024 - Zacks Investment Research
The volume for Amedisys stock increased for two consecutive days, resulting in a record-breaking daily growth of 162% of the 65-Day Volume Moving Average
2/29/2024 - Tickeron - Stocks
A Balanced View: Growth and Challenges at Amedisys Amidst Pending Acquisition by UnitedHealth
2/26/2024 - TipRanks Financial Blog
Amedisys' (AMED) Q4 Earnings Miss Estimates, Margins Up
2/23/2024 - Zacks Investment Research
Amedisys Non-GAAP EPS of $0.94 misses by $0.05, revenue of $570.8M misses by $0.83M
2/22/2024 - SeekingAlpha.com: All News
Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say
2/22/2024 - Zacks Investment Research
Income Statement
Total Revenue (TTM)
$2.24B
EBITDA (TTM)
$196.74M
EBIT (TTM)
$172.90M
Net Income (TTM)
-$9.75M
Balance Sheet
Total Assets (Q)
$2.06B
Total Debt (Q)
$487.21M
Total Liabilities (Q)
$940.39M
Book Value Per Share (Q)
$32.65
Cash Flow
Cash from Operations (TTM)
$137.19M
Cash from Investing (TTM)
$35.06M
Cash from Financing (TTM)
-$87.52M
Net Change in Cash (TTM)
$84.73M
Filings
Filing Date
Thursday, February 22, 2024
Period Date
Sunday, December 31, 2023
Next Filing
Beginning of May (est)
Price History
Loading...
Beta
0.52
7-Day Total Return
0.91%
30-Day Total Return
-1.07%
60-Day Total Return
-2.63%
90-Day Total Return
-2.92%
Year to Date Total Return
-3.35%
1-Year Total Return
19.75%
2-Year Total Return
-30.11%
3-Year Total Return
-68.18%
5-Year Total Return
-28.23%
52-week Low
May 11, 2023 - $73.10
52-week High
Dec 19, 2023 - $96.44
Valuation
Market Cap
$2.95B - Mid Cap
Enterprise Value
$3.37B
Price/Sales (TTM)
1.33
Price/Book (Q)
2.77
Dividends and Shares
Shares Outstanding
32.91M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.amedisys.com
Phone Number
225 292 2031
Address
3854 American Way
Baton Rouge, LA 70816
Country
United States
Year Founded
1982
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health... more
NASDAQ 04/26/2024 4:00PM Eastern Quotes delayed
Weiss Ratings